Expand AMGN Menu
AMGN MENU

AMGN Latest Press Releases

-- April 16, 2024 --

AMGEN TO PRESENT TEZSPIRE PHASE 2A COPD DATA AT ATS 2024 PRNewswire 5:26 PM

-- March 9, 2024 --

AMGEN PRESENTS NEW RESEARCH ON OTEZLA (APREMILAST) AT AAD 2024 PRNewswire 12:20 PM

-- March 6, 2024 --

AMGEN ANNOUNCES 2024 SECOND QUARTER DIVIDEND PRNewswire 4:00 PM

-- February 29, 2024 --

AMGEN TO PRESENT AT THE 44TH ANNUAL TD COWEN HEALTH CARE CONFERENCE PRNewswire 4:00 PM

-- February 26, 2024 --

AMGEN OPENS STATE-OF-THE-ART BIOMANUFACTURING SITE IN CENTRAL OHIO PRNewswire 9:00 AM

-- February 20, 2024 --

RedHill's Opaganib Protects Against Radiation-Induced Lung Inflammation and Fibrosis - New Publication PRNewswire 7:00 AM

-- February 19, 2024 --

AMGEN TO HOST CONFERENCE CALL ON RARE DISEASE PRNewswire 4:00 PM

-- February 9, 2024 --

AMGEN TO PRESENT AT THE 34TH ANNUAL OPPENHEIMER HEALTHCARE LIFE SCIENCES CONFERENCE PRNewswire 4:00 PM

-- February 6, 2024 --

AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS PRNewswire 4:01 PM

-- February 1, 2024 --

AMGEN ANNOUNCES WEBCAST OF 2023 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS PRNewswire 4:00 PM

-- January 29, 2024 --

deCODE genetics: A sequence variant that increases risk of pregnancy loss PRNewswire 5:00 AM

-- January 9, 2024 --

Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030 Globe Newswire 10:25 AM

-- January 4, 2024 --

Generate:Biomedicines Fortifies Leadership in Generative AI with Advancing Clinical Pipeline and Expanded Amgen Collaboration, Overviewed at the 42nd Annual J.P. Morgan Healthcare Conference Business Wire 6:00 AM

-- January 3, 2024 --

AMGEN TO PRESENT AT THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE PRNewswire 4:00 PM

-- December 26, 2023 --

AMGEN PROVIDES REGULATORY UPDATE ON STATUS OF LUMAKRAS (SOTORASIB) PRNewswire 9:00 AM

-- December 14, 2023 --

AMGEN ANNOUNCES EXECUTIVE APPOINTMENTS TO ACCELERATE INNOVATION PRNewswire 9:00 AM
AMGEN TO SPONSOR THE IRISH OPEN PRNewswire 5:00 AM

-- December 13, 2023 --

FDA Grants Priority Review to Amgen's Tarlatamab Application for Advanced Small Cell Lung Cancer PRNewswire 4:00 PM

-- December 12, 2023 --

AMGEN ANNOUNCES 2024 FIRST QUARTER DIVIDEND INCREASE TO $2.25 PER SHARE PRNewswire 4:00 PM

-- November 22, 2023 --

AMGEN TO PRESENT AT THE EVERCORE ISI HEALTHCONX CONFERENCE PRNewswire 4:00 PM